MedPath
NMPA Approval

Furmonertinib Mesilate Tablets

国药准字H20210008

June 28, 2022

Drug Information

甲磺酸伏美替尼片

艾弗沙

片剂

40mg(按C₂₈H₃₁F₃N₈O₂计)

化学药品

June 28, 2022

Company Information

Applicant Company

上海市浦东新区周浦镇凌霄花路268号

Manufacturing Company

启东经济开发区华石路666号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸伏美替尼片 - NMPA 批准文号 | MedPath